Study ties sleep quality to osteoarthritis pain tolerance | Ultrasound scores correlate with psoriatic arthritis assessments | Review examines strong association between obesity, pain

July 22, 2015
News for the pain professional

Pain Research News
Study ties sleep quality to osteoarthritis pain tolerance
Uninterrupted sleep throughout the night may help improve osteoarthritis patients' pain tolerance, according to new research. The study, which appeared in The Journal of Pain, found an association between how the body handles pain and sleep quality, and the authors advise consideration of interventions to address sleep issues in osteoarthritis patients with insomnia. HealthDay News (7/17)
Share: LinkedInTwitterFacebookGoogle+Email
Ultrasound scores correlate with psoriatic arthritis assessments
A study of 83 psoriatic arthritis patients found a substantial correlation between power Doppler ultrasound scores of greater than 10 and the Evaluator's Global Assessment and patient assessments of pain, researchers reported at the European League Against Rheumatism Annual European Congress of Rheumatology. While the Patient's Global Assessment and EGA scores did not agree in 65% of cases, data did show a strong correlation between psoriatic arthritis patients who had high erosion scores and EGA and patient pain assessments. Healio (free registration) (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Making Work-Life Balance Work
For startups or established enterprises, juggling the demands of work and the rest of your day means knowing what's important, setting boundaries and getting creative. Click here to read Boomtown: Think Like a Startup

Treatment News
Diabetic neuropathy pain responds to inhaled cannabis, study finds
Patients with diabetic neuropathy showed improvement in pain response scores after inhaled cannabis therapy, and the reduction was dependent on dosage, researchers reported in The Journal of Pain. Researchers from the University of California, San Diego, said data from the study, which compared three dosages and a placebo, showed cannabis therapy had modest effects on cognition. (7/20)
Share: LinkedInTwitterFacebookGoogle+Email
Experimental cancer pain drug fails to reach primary goals
In a midstage clinical trial, adding the investigational drug fulranumab, an anti-nerve growth factor, to opioid therapy did not significantly reduce pain intensity or adequately control pain among terminally ill cancer patients. The placebo-controlled research, reported at a meeting of the Multinational Association of Supportive Care in Cancer, did find response rates to be greater than 30% with fulranumab. Medscape (free registration) (7/20)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Policy & Trends
Many Medicare patients report bothersome pain, study finds
Study data on older patients with dementia who lived at home found 64% had bothersome pain and 43% had pain that limited their ability to do daily activities. Researchers from the University of California, San Francisco, reported in the Journal of the American Geriatrics Society that among Medicare beneficiaries without dementia who lived at home, 55% had bothersome pain and 27% said pain limited their activities. HealthDay News (7/22)
Share: LinkedInTwitterFacebookGoogle+Email
Pills' appearances color patients' expectations, study finds
Patients in the U.S., China and Colombia estimate a pill's effectiveness and ease of use based on its color and shape, according to a study in the journal Food Quality and Preference. Study participants viewed white pills as most effective for headaches and rated red and blue pills as harder to swallow. The Wall Street Journal (tiered subscription model) (7/20)
Share: LinkedInTwitterFacebookGoogle+Email
APS News
Recognize your colleagues
Each year APS presents eight prestigious awards at its Annual Scientific Meeting. Nominations for these awards are now open. If you would like to nominate a colleague for any of the awards, please complete the electronic form. The deadline is this Friday, July 24. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
Connect with members and join a Shared Interest Group
Share and exchange your professional challenges and interests by joining a Shared Interest Group. SIGs are a forum where APS members can meet and discuss a field or topic of common interest. There are 18 SIGs that cover APS' multidisciplinary approach to pain research and treatment. Areas of interest include education, nursing, palliative care, basic science, primary care, clinical trials and more. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
Success depends upon previous preparation, and without such preparation there is sure to be failure."
-- Confucius,
philosopher and teacher
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about APS ->Membership | Annual Meeting | Education | Funding Opportunities | About Us
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Tom Parks
Advertising:  Wynn Hansen
  P: 202.470.1149

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information